Summary
Lymphocytic infiltrate is often present in cervical cancer lesions, possibly reflecting an ongoing, but ineffective, immune response to the tumour. Recently, evidence has accumulated for systemically impaired T-cell functions in cancer patients, associated with decreased expression of signal-transducing zeta (ζ) chain dimer molecules on circulating T-cells and NK-cells. Here, we report on the intralesional down-regulation of ζ chain expression on T-cells in cervical carcinoma. Paraffin-embedded or snap-frozen sections from 24 different cervical cancer specimens were studied. Paraffin-embedded tumour-positive (n = 7) and tumour-negative (n = 15) pelvic lymph nodes were also included in the study. Immunostaining was performed on consecutive sections with antibodies specific for CD3-ɛ or the CD3-associated ζ chain dimer. Antigen retrieval by sodium citrate/microwave treatment was essential for ζ staining of paraffin sections. The amount of ζ positive cells was quantitated and related to the number of CD3-ɛ+ cells in corresponding tumour areas. Of the 24 cervical cancer specimens studied, ζ chain dimer expression was reduced in seven cases and strongly reduced in the other 17 samples. In tonsil control sections, CD3-ɛ and CD3-ζ were always co-expressed in almost equal numbers. Also, both tumour-negative and -positive lymph nodes showed ζ chain expression which equalled that of CD3-ɛ expression. These data indicate that a decreased expression of signal-transducing ζ molecules on tumour-infiltrating T-cells is frequent in cervical cancer. The apparently unimpaired ζ chain expression within draining lymph nodes suggests that local tumour-derived factors at the primary site are instrumental in ζ chain down-regulation.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bontkes, H. J., de Gruijl, T. D., Walboomers, J. M. M., van den Muysenberg, A. J. C., Gunther, A. W., Scheper, R. J., Meijer, CJLM & Kummer, J. A. (1997). Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions. Br J Cancer 76: 1353–1360.
Chouaib, S., Asselin-Paturel, C., Mami-Chouaib, F., Caignard, A. & Blay, J. Y. (1997). The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol Today 18: 493–497.
Correa, M. R., Ochoa, A. C., Ghosh, P., Mizoguchi, H., Harvey, L. & Longo, D. L. (1997). Sequential development of structural and functional alterations in T cells from tumor-bearing mice. J Immunol 158: 5292–5296.
Cromme, F. V., Meijer, CJLM, Snijders, P. J. F., Uyterlinde, A., Kenemans, P., Helmerhorst, T., Stern, P. L., Vandenbrule, A. J. C. & Walboomers, J. M. M. (1993). Analysis of MHC class-I and class-II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. Br J Cancer 67: 1372–1380.
Cromme, F. V., Walboomers, J. M. M., Stukart, M. J., de Gruijl, T. D., Kummer, J. A., Leonhart, A. M., Helmerhorst, T. J. M. & Meijer, CJLM (1995). Lack of granzyme expression in T lymphocytes indicates poor cytotoxic T lymphocyte activation in human papillomavirus-associated cervical carcinomas. Int J Gynecol Cancer 5: 366–373.
de Gruijl, T. D., Bontkes, H. J., Stukart, M. J., Walboomers, J. M. M., Remmink, A. J., Verheijen, R. H. M., Helmerhorst, T. J. M., Meijer, CJLM & Scheper, R. J. (1996a). T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection. J Gen Virol 77: 2183–2191.
de Gruijl, T. D., Bontkes, H. J., Walboomers, J. M. M., Stukart, M. J., Robbesom, AAJP, von Blomberg-van der Flier, B. M. E., Herbrink, P., Remmink, A. J., Verheijen, R. H. M., Helmerhorst, T. J. M., Meijer, CJLM & Scheper, R. J. (1996b). Analysis of IgG reactivity against human papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study. Int J Cancer 68: 731–738.
Finke, J. H., Zea AH Longo, D. L., Mizoguchi, H., Tubbs, R. R., Wiltrout, R. H., O’Shea, J. J., Kudou, S., Klein, E., Bukowski, R. M. & Ochoa, A. (1993). Loss of T-cell receptor zeta chain and P56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res 53: 5613–5616.
Frazer, I. H. (1996). Immunology of papillomavirus infection. Curr Op Immunol 8: 484–491.
IARC (1995). Monographs on the Evaluation of the Carcinogenic Risks to Humans, vol. 64, The Human Papillomavirus, International Agency for Research on Cancer: Lyon
Kiessling, R., Kono, K., Petersson, M. & Wasserman, K. (1996). Immunosuppression in human tumor-host interaction: role of cytokines and alterations in signal-transducing molecules. Springer Sem Immunopatol 18: 227–242.
Kono, K., Ressing, M. E., Brandt, R. M. P., Melief, C. J. M., Potkul, R. K., Andersson, B., Petersson, M., Kast, W. M. & Kiessling, R. (1996a). Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Cancer Res 2: 1825–1828.
Kono, K., Salazar-Onfray, F., Petersson, M., Hansson, J., Masucci, G., Wasserman, K., Nakazawa, T., Andersson, P. & Kiessling, R. (1996b). Hydrogen peroxide secreted by macrophages/monocytes inhibits tumor specific T-cell and NK mediated cytotoxicity and down-regulates expression expression of signal-transducing molecules. Eur J Immunol 26: 1308–1313.
Lai, P., Rabinowich, H., Crowley-Nowick, P. A., Bell, M. C., Mantovani, G. & Whiteside, T. L. (1996). Alterations in expression and function of signal-transducing proteins in tumour-associated T and natural killer cells in patients with ovarian carcinoma. Clin Cancer Res 2: 161–173.
Levey, D. L. & Srivastava, P. K. (1996). Alterations in T cells of cancer-bearers: whence specificity? Immunol Today 17: 365–368.
Matsuda, M., Petersson, M., Lenkei, R., Taupin, J-L, Magnusson, I., Mellstedt, H., Andersson, P. & Kiessling, R. (1995). Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int J Cancer 61: 765–772.
Matzinger, P. (1994). Tolerance, danger and the extended family. Annu Rev Immunol 12: 991–1045.
Maurice, M. M., Lankester, A. C., Bezemer, A. C., Geertsma, M. F., Tak, P. P., Breedveld, F. C., van Lier, R. A. W. & Verweij, C. L. (1998). Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis. J Immunol 159: 2973–2978.
Mizoguchi, H., O’Shea, J. J., Longo, D. L., Loeffler, C. M., McVicar, D. W. & Ochoa, A. (1992). Alterations in signal transduction molecules in T-lymphocytes from tumor bearing mice. Science 258: 1795–1798.
Mulder, W. M. C., Bloemena, E., Stukart, M. J., Kummer, J. A., Wagstaff, J. & Scheper, R. J. (1997). T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma. Gut 40: 113–119.
Nakagomi, H., Petersson, M., Magnusson, I., Juhlin, C., Matsuda, M., Mellstedt, H., Taupin, J-L, Vivier, E., Anderson, P. & Kiessling, R. (1993). Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res 53: 5610–5612.
Robey, E. & Allison, J. P. (1995). T-cell activation: integration of signals from the antigen receptor and costimulatory molecules. Immunol Today 16: 306–310.
Rosenberg, A. S. (1996). Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens. J Natl Cancer Inst 88: 1635–1644.
Tartour, E., Latour, S., Mathiot, C., Thiounn, N., Mosseri, V., Joyeux, I., D’Enghien, C. D., Lee, R., Derbre, B. & Fridman, W. H. (1995). Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int J Cancer 63: 205–212.
Whiteside, T. L., Jost, L. M. & Herbermann, R. B. (1992). Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy. Crit Rev Oncol Hematol 12: 25–47.
Zea, A. H., Curti, B. D., Longo, C. D., Alvord, W. G., Srobl, S. L., Mizoguchi, H., Creekmore, S. P., O’Shea, J. J., Powers, G. C., Urba, W. J. & Ochoa, A. C. (1995). Alteration in T cell receptor and signal transduction molecules in melanoma patients. Clin Cancer Res 1: 1327–1335.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
de Gruijl, T., Bontkes, H., Peccatori, F. et al. Expression of CD3-ζ on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes. Br J Cancer 79, 1127–1132 (1999). https://doi.org/10.1038/sj.bjc.6690179
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690179
Keywords
This article is cited by
-
CD3ζ Expression and T Cell Proliferation are Inhibited by TGF-β1 and IL-10 in Cervical Cancer Patients
Journal of Clinical Immunology (2009)
